Key Highlights
- Peter Carbone, with 35 years of experience, is appointed as Chief Quality Officer at KBI Biopharma.
- Carbone will lead KBI’s Quality and Regulatory Affairs team, focusing on compliance and regulatory initiatives worldwide.
- His vast experience includes roles at Bayer, Amgen, Allergan, Novartis, Acorda, and the Center of Breakthrough Medicines.
Source: Business Wire
Notable Quotes
- “We are poised for remarkable advancements in the biopharma industry, and I look forward to working with this talented team to drive innovation, ensure quality, deliver exceptional results, and ultimately make a meaningful impact on patients’ lives worldwide.” – Peter Carbone, Chief Quality Officer at KBI Biopharma
- “Peter’s addition to our team bolsters our expertise in quality and regulatory compliance and facilitates our continued transformation in support of our current and future customers.” – J.D. Mowery, President & CEO at KBI Biopharma
SoHC's Take
Peter Carbone’s appointment as Chief Quality Officer at KBI Biopharma marks a significant milestone for the company in its quest to lead in quality and regulatory affairs within the biopharma industry. His vast experience and proven leadership in operations, quality, and technology across various life sciences sectors are poised to drive KBI towards innovative advancements. Carbone’s leadership will enhance KBI’s ability to partner effectively with health authorities and support the life sciences industry’s evolution with high-quality, innovative solutions. His commitment to making a difference in patients’ lives aligns with KBI’s mission, promising a future of groundbreaking achievements in biopharmaceuticals.
